CID 17747460

Gsk-1004723

Structural Information

Molecular Formula
C39H49ClN4O2
SMILES
C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCCCN3CCC[C@@H]3CN4C(=O)C5=CC=CC=C5C(=N4)CC6=CC=C(C=C6)Cl
InChI
InChI=1S/C39H49ClN4O2/c40-33-19-15-32(16-20-33)29-38-36-13-3-4-14-37(36)39(45)44(41-38)30-34-12-9-27-43(34)26-8-5-11-31-17-21-35(22-18-31)46-28-10-25-42-23-6-1-2-7-24-42/h3-4,13-22,34H,1-2,5-12,23-30H2/t34-/m1/s1
InChIKey
YANGEESWIGIKOP-UUWRZZSWSA-N
Compound name
2-[[(2R)-1-[4-[4-[3-(azepan-1-yl)propoxy]phenyl]butyl]pyrrolidin-2-yl]methyl]-4-[(4-chlorophenyl)methyl]phthalazin-1-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

7
References

156
Patents

640.35443 Da
Monoisotopic Mass

8.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 641.36171 270.1
[M+Na]+ 663.34365 283.2
[M+NH4]+ 658.38825 275.0
[M+K]+ 679.31759 273.2
[M-H]- 639.34715 277.6
[M+Na-2H]- 661.32910 275.9
[M]+ 640.35388 274.5
[M]- 640.35498 274.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe